Singapore markets closed

Sino Biopharmaceutical Limited (1177.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.340-0.090 (-3.70%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
28,863,711
28,780,412
26,861,356
23,647,224
Cost of revenue
6,092,416
5,795,510
5,332,095
5,182,320
Gross profit
22,771,295
22,984,902
21,529,261
18,464,904
Operating expenses
Research development
-
-
-
2,626,709
Selling general and administrative
12,074,467
12,564,007
12,703,627
11,628,561
Total operating expenses
11,686,591
12,389,024
12,541,759
11,422,834
Operating income or loss
11,084,704
10,595,878
8,987,502
7,042,070
Interest expense
573,924
439,058
308,617
323,368
Income before tax
5,248,159
5,778,604
18,572,673
5,013,044
Income tax expense
729,338
775,986
1,957,880
672,377
Income from continuing operations
4,518,821
5,002,618
16,614,793
4,340,667
Net income
1,881,317
2,543,570
14,608,412
2,771,086
Net income available to common shareholders
1,881,317
2,543,570
14,608,412
2,771,086
Basic EPS
0.10
0.14
0.78
0.15
Diluted EPS
0.10
0.12
0.73
0.15
Basic average shares
18,574,919
18,622,249
18,768,650
18,800,284
Diluted average shares
18,737,912
19,017,202
19,282,955
18,800,284